APA (7th ed.) Citation

Balinda, H. U., Kelly, W. J., Kaklamani, V. G., Lathrop, K. I., Canola, M. M., Ghamasaee, P., . . . Brenner, A. J. (2024, August). Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: A phase 0 window-of-opportunity trial. Nature Communications.

Chicago Style (17th ed.) Citation

Balinda, Henriette U., et al. "Sacituzumab Govitecan in Patients with Breast Cancer Brain Metastases and Recurrent Glioblastoma: A Phase 0 Window-of-opportunity Trial." Nature Communications Aug. 2024.

MLA (9th ed.) Citation

Balinda, Henriette U., et al. "Sacituzumab Govitecan in Patients with Breast Cancer Brain Metastases and Recurrent Glioblastoma: A Phase 0 Window-of-opportunity Trial." Nature Communications, Aug. 2024.